Clinical Trial Update: Safety of Atezolizumab-Bevacizumab in Liver Transplanted Patients With Advanced Hepatocellular Carcinoma [Phase 2]

View source ↗

Summary

Phase 2 clinical trial assessing safety of the atezolizumab-bevacizumab combination in liver transplant recipients with advanced hepatocellular carcinoma; curre…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatocellular Carcinoma

Drugs mentioned

• Avastin (bevacizumab) (bevacizumab)
• Tecentriq (atezolizumab) (atezolizumab)

Snippet

Sponsor: Assistance Publique - Hôpitaux de Paris | Conditions: Liver Transplant, Hepatocellular Carcinoma Recurrent | Phase 2 | Status: RECRUITING